Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

LORNOLIOF™ lyophilisate for injection solution 8mg, 5 vials + 5 solvent ampoules 2ml

🔥 8 items sold in last 3 hours
25 people are viewing this product
Brand:
Active Ingredient:

Manufacturer:

$59.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

L-THYROXINE BERLIN-CHEMIE™ tablets 50mcg, 50pcs

$7.00
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 75mcg, 100pcs

$10.00
Add to cart

Analogs of LORNOLIOF™

XEFOCAM™ lyophilisate for intravenous and intramuscular injection solution 8mg, 5pcs

$102.00
Add to cart

XEFOCAM™ RAPID tablets 8mg, 12pcs

$41.00
Add to cart

XEFOCAM™ tablets 8mg, 10pcs

$30.00
Add to cart

XEFOCAM™ tablets 8mg, 10pcs

$34.00
Add to cart

Table of Contents

LORNOLIOF™ 8mg Lyophilisate 5pcs Buy Online

Lornoliof: A Comprehensive Overview

Experiencing debilitating pain? Lornoliof, a potent analgesic, may offer relief. This comprehensive overview explores its uses, administration, and potential benefits and risks.

What is Lornoliof?

Lornoliof is a lyophilized powder for injection, containing lornoxicam, a nonsteroidal anti-inflammatory drug (NSAID). It’s available in vials containing 8mg of lornoxicam, requiring reconstitution with a provided solvent before administration.

Lornoliof is indicated for the short-term treatment of mild to moderate acute pain. Its analgesic and anti-inflammatory properties make it suitable for managing pain associated with conditions such as osteoarthritis and rheumatoid arthritis.

Each vial of Lornoliof (8mg) is reconstituted with 2ml of the provided sterile water for injection. The resulting solution is then administered either intravenously or intramuscularly. Specific dosage and administration instructions should always be followed as directed by a healthcare professional.

Lornoxicam, the active component, inhibits the production of prostaglandins, inflammatory mediators responsible for pain and swelling. By reducing prostaglandin synthesis, Lornoliof effectively alleviates pain and reduces inflammation.

Pros

  • Effective pain relief: Provides rapid and effective relief from mild to moderate pain.
  • Anti-inflammatory action: Reduces inflammation associated with various conditions.
  • Multiple administration routes: Can be administered intravenously or intramuscularly, offering flexibility.

Cons

  • Gastrointestinal issues: Like other NSAIDs, it may cause gastrointestinal upset in some individuals.
  • Allergic reactions: The possibility of allergic reactions, ranging from mild skin rashes to more serious reactions, exists.
  • Drug interactions: Potential for interactions with other medications; consult a healthcare provider about any other medications being taken.

Precautions and Contraindications

Consult a healthcare professional before using Lornoliof, especially if you have a history of gastrointestinal problems, allergies to NSAIDs, or other relevant medical conditions. Lornoliof is not suitable for everyone and should be used under appropriate medical supervision.

Further Considerations

Always follow the prescribed dosage and administration instructions carefully. Report any adverse effects to your healthcare provider immediately. This information is not a substitute for professional medical advice.

Conclusion

Lornoliof offers a potent solution for managing mild to moderate acute pain and inflammation. However, potential risks must be carefully weighed against the benefits, and its use should always be under the guidance of a healthcare professional.

What is Lornoliof?

Lornoliof is a prescription medication presented as a lyophilized powder for injection. This means it’s a dried powder that needs to be reconstituted with a sterile solvent before use. The active pharmaceutical ingredient is lornoxicam, a nonsteroidal anti-inflammatory drug (NSAID) belonging to the oxicam class. This class of drugs is known for its potent analgesic (pain-relieving) and anti-inflammatory properties, making it effective in managing various types of pain and inflammation.

Each package of Lornoliof typically contains five 8mg vials of lornoxicam lyophilisate and five 2ml ampoules of sterile water for injection, the solvent necessary for reconstitution. The lyophilized powder itself is usually described as a yellowish powder or a compacted mass. The reconstitution process is crucial; it transforms the dry powder into a solution suitable for intravenous or intramuscular administration. Improper reconstitution can compromise the medication’s efficacy and safety. Therefore, adherence to the manufacturer’s instructions is paramount. Always consult with a healthcare professional for proper handling and administration.

It’s important to understand that Lornoliof is not an over-the-counter medication and should only be used under the strict guidance of a physician. The drug is intended for the short-term management of specific pain conditions, and its use should be tailored to individual patient needs and medical history. The potential benefits must always be carefully weighed against the potential risks associated with NSAID use, including gastrointestinal effects and allergic reactions. Remember, self-medicating with Lornoliof or any prescription medication is strongly discouraged.

Uses and Indications

Lornoliof’s primary application lies in the short-term management of acute pain. Its effectiveness is particularly notable in cases of mild to moderate pain intensity. This makes it a valuable tool in addressing various painful conditions, offering relief where other treatments might be insufficient or inappropriate.

Specific conditions where Lornoliof may be prescribed include the symptomatic treatment of pain and inflammation associated with osteoarthritis. This chronic degenerative joint disease often causes significant discomfort, and Lornoliof can help alleviate the associated pain and inflammation. Additionally, it may be used to manage pain and inflammation related to rheumatoid arthritis, an autoimmune disorder that affects the joints.

Beyond these specific arthritic conditions, Lornoliof can find application in treating a broader range of acute pain syndromes. Examples include post-operative pain, where its rapid onset of action can prove beneficial. Other examples include pain associated with migraine headaches, dental pain, muscular pain (myalgia), and nerve pain (neuralgia). However, it’s crucial to remember that Lornoliof is intended for short-term use and should not be considered a long-term pain management solution. The decision to prescribe Lornoliof should always rest with a qualified healthcare professional, considering the patient’s individual circumstances and medical history.

The versatility of Lornoliof, coupled with its analgesic and anti-inflammatory properties, makes it a potentially valuable option for the management of various types of pain, but always under appropriate medical supervision. Its use should be carefully considered, balancing potential benefits against known risks associated with NSAID use. A healthcare professional’s guidance is vital in ensuring safe and effective treatment.

Administration and Dosage

Lornoliof is administered parenterally, meaning it bypasses the digestive system. This method allows for faster absorption and quicker onset of action compared to oral medications. The two primary routes of administration are intravenous (IV) injection and intramuscular (IM) injection. The choice between these routes depends on various factors, including the patient’s condition and the physician’s clinical judgment.

Before administration, the lyophilized lornoxicam powder must be carefully reconstituted. This involves adding the provided sterile water for injection to the vial containing the powder. Gentle swirling or shaking is necessary to dissolve the powder completely, creating a clear solution. The manufacturer’s instructions should be followed precisely to ensure proper reconstitution. Using the incorrect amount of solvent or employing improper reconstitution techniques could compromise the drug’s efficacy and safety.

For intravenous administration, the reconstituted solution is injected directly into a vein over a period of at least 15 seconds. Intramuscular injection, on the other hand, involves injecting the solution into a muscle using a longer needle. The injection site should be chosen carefully to minimize discomfort and potential complications. For intramuscular administration, injection should occur over at least 5 seconds. The specific dosage of Lornoliof is determined by the prescribing physician based on the patient’s individual needs, the severity of the pain, and other relevant clinical factors. It is crucial to strictly adhere to the prescribed dosage and administration instructions to maximize therapeutic benefit and minimize the risk of adverse events. Improper dosage or administration can lead to reduced effectiveness or potentially harmful side effects.

It is absolutely vital that Lornoliof is administered only by or under the direct supervision of a healthcare professional who is trained in parenteral medication administration. Improper administration techniques can lead to complications. Always follow the prescribed dosage regimen provided by your physician; never exceed the recommended dose or frequency without explicit medical guidance. Patient safety is paramount, and adhering to proper administration protocols is crucial for successful and safe treatment.

Mechanism of Action

Lornoliof exerts its therapeutic effects primarily through the inhibition of cyclooxygenase (COX) enzymes. These enzymes play a crucial role in the biosynthesis of prostaglandins, potent inflammatory mediators responsible for pain, fever, and inflammation. By selectively inhibiting COX enzymes, lornoxicam, the active component of Lornoliof, effectively reduces the production of these inflammatory substances.

This reduction in prostaglandin synthesis is the key mechanism underlying Lornoliof’s analgesic (pain-relieving) and anti-inflammatory effects. The decreased levels of prostaglandins lead to a reduction in pain perception and a decrease in the inflammatory response in affected tissues. This dual mechanism of action contributes to Lornoliof’s effectiveness in managing various pain conditions, particularly those involving inflammation.

While the precise mechanisms of action may vary slightly depending on the specific COX isoforms involved, the overall effect remains consistent: a reduction in pain and inflammation. It’s important to note that, like other NSAIDs, Lornoliof’s mechanism is not fully elucidated, and other pathways might contribute to its overall therapeutic impact. Further research continues to unravel the complexities of NSAID pharmacology and their interactions within the body’s intricate biological systems. Understanding these mechanisms is crucial for optimizing the use of Lornoliof and minimizing potential adverse effects.

The precise details of lornoxicam’s interactions with COX-1 and COX-2 isoforms, and the resulting impact on various physiological processes, remain areas of ongoing investigation. This ongoing research is essential for refining our understanding of NSAID pharmacology and improving the safety and efficacy of pain management strategies. Further studies are vital to fully characterize the complex interplay between lornoxicam and the body’s intricate biological systems.

Potential Benefits

Lornoliof offers several key advantages in managing pain and inflammation. Its primary benefit is the provision of rapid and effective pain relief. This quick onset of action is particularly valuable in situations requiring immediate pain management, such as post-surgical pain or acute flare-ups of arthritic conditions. The parenteral route of administration contributes significantly to this rapid relief.

Beyond its analgesic properties, Lornoliof also demonstrates potent anti-inflammatory effects. This dual action—pain relief and inflammation reduction—is crucial in managing conditions like osteoarthritis and rheumatoid arthritis, where both pain and inflammation contribute significantly to patient discomfort and functional impairment. By targeting both aspects, Lornoliof can improve patients’ overall well-being and quality of life.

The availability of both intravenous and intramuscular routes of administration provides flexibility in treatment strategies. This adaptability is important because it allows healthcare professionals to select the most appropriate route based on the patient’s specific needs and clinical circumstances. Intravenous administration offers the fastest onset of action, while intramuscular injection provides a more convenient option for less urgent situations. This versatility enhances the overall utility of Lornoliof as a pain management tool.

Furthermore, the short-term nature of Lornoliof’s intended use helps to minimize the risk of long-term side effects often associated with chronic NSAID use. While side effects are still possible, limiting the duration of treatment can potentially reduce the incidence and severity of such complications. This aspect is particularly important for patients with pre-existing health conditions or those at higher risk of adverse reactions to NSAIDs. Always consult with a healthcare professional to weigh the potential benefits against the potential risks.

Pros

  • Rapid Pain Relief: Lornoliof provides swift and effective pain relief, making it particularly beneficial for acute pain situations requiring immediate intervention. The intravenous route, in particular, ensures a fast onset of action, offering prompt comfort to patients suffering from severe pain.
  • Dual Action Mechanism: Its ability to both alleviate pain and reduce inflammation makes it a powerful tool against conditions like osteoarthritis and rheumatoid arthritis, where both symptoms significantly impact a patient’s quality of life. This dual approach addresses the core issues driving discomfort.
  • Versatile Administration: The option of intravenous or intramuscular administration offers flexibility in treatment, allowing healthcare professionals to tailor the delivery method to suit the individual patient’s needs and the urgency of the situation. This adaptability is crucial in various clinical settings.
  • Short-Term Treatment: The medication is primarily intended for short-term use, thus minimizing the potential for long-term side effects commonly associated with prolonged NSAID use. This approach prioritizes safety by limiting potential exposure to adverse reactions.
  • Targeted Relief: Lornoliof effectively targets the source of pain and inflammation, offering focused relief without unnecessarily impacting other bodily functions. This targeted approach minimizes unnecessary side effects while maximizing therapeutic benefit.

Potential Risks

While Lornoliof offers significant benefits in pain and inflammation management, it’s crucial to acknowledge potential risks associated with its use. Like other NSAIDs, Lornoliof can cause gastrointestinal side effects. These range from mild discomfort, such as indigestion or heartburn, to more severe complications, including stomach ulcers or gastrointestinal bleeding. The risk of such complications is generally higher in individuals with pre-existing gastrointestinal conditions or those taking other medications that can increase this risk.

Allergic reactions, while relatively uncommon, are a possibility. These can manifest in various ways, from mild skin rashes and itching to more serious reactions like angioedema (swelling of the face, lips, or tongue) or anaphylaxis (a life-threatening allergic reaction). Individuals with a known allergy to NSAIDs or a history of allergic reactions should exercise particular caution and consult their physician before using Lornoliof. Immediate medical attention is necessary if a severe allergic reaction occurs.

Furthermore, Lornoliof, like other NSAIDs, can affect renal function in some individuals, particularly those with pre-existing kidney problems. Prolonged or excessive use can potentially impair kidney function, leading to complications. Regular monitoring of kidney function may be necessary, especially in at-risk patients. Individuals with impaired kidney function should discuss the risks and benefits with their healthcare provider before starting treatment with Lornoliof.

Finally, interactions with other medications can occur. Concomitant use of Lornoliof with certain drugs, such as anticoagulants (blood thinners) or other NSAIDs, can increase the risk of bleeding or other adverse effects. It’s essential to inform your doctor about all medications, supplements, or herbal remedies you are currently taking to avoid potential drug interactions. Always consult your physician before starting any new medication, including Lornoliof, to minimize the risk of unexpected adverse events.

  • Lornoliof™ Lyophilisate For Injection Solution 8Mg, 5 Vials + 5 Solvent Ampoules 2Ml Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Lornoliof™ Lyophilisate For Injection Solution 8Mg, 5 Vials + 5 Solvent Ampoules 2Ml Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Lornoliof™ Lyophilisate For Injection Solution 8Mg, 5 Vials + 5 Solvent Ampoules 2Ml Buy Online 6
    [Medical reviewer]

    Dr. Elizabeth Dennis is a highly skilled Orthopedic Surgeon and consultant for RxPulsar.com, a licensed online pharmacy. She specializes in the management and surgical treatment of knee, shoulder, and...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “LORNOLIOF™ lyophilisate for injection solution 8mg, 5 vials + 5 solvent ampoules 2ml”

Your email address will not be published. Required fields are marked

Similar products

NOVEMA™ NIGHT tablets 25mg+220mg, 10pcs

$25.00
Add to cart

NOVIGAN™ LADY tablets 80mg+400mg, 10pcs

$16.00
Add to cart

NOVALGIN™ tablets 50mg+200mg+200mg, 10pcs

$20.00
Add to cart

NIASPAM™ tablets 135mg, 50pcs

$36.00
Add to cart

NIASPAM™ prolonged-release capsules 200mg, 30pcs

$26.00
Add to cart

NIASPAM™ tablets 135mg, 30pcs

$22.00
Add to cart

MEBEVERIN-VERTEX™ prolonged-release capsules 200mg, 30pcs

$28.00
Add to cart

MEBESPALIN™ tablets 135mg, 50pcs

$37.00
Add to cart

LORNOXICAM-TRIVIUM™ lyophilisate for injection solution 8mg, 5pcs

$53.00
Add to cart

KETOPROFEN-AKOS™ topical gel 5% (100g), 1pc

$26.00
Add to cart

KETOPROFEN-AKOS™ topical gel 5% (50g), 1pc

$25.00
Add to cart

KETOPROFEN-AKOS™ solution for IV and IM injection 50mg/ml (2ml), 10 ampoules

$16.00
Add to cart

CAFFETIN™ LIGHT tablets, 12pcs

$11.00
Add to cart

KALMIREX™ tablets 150mg, 30pcs

$30.00
Add to cart

KALMIREX™ tablets 50mg, 30pcs

$27.00
Add to cart

DROTAVERINE tablets 40mg, 100pcs

$11.00
Add to cart

DROTAVERINE tablets 40mg, 20pcs

$6.00
Add to cart

DROTAVERINE tablets 40mg, 50pcs

$7.00
Add to cart

DROTAVERINE tablets 80mg, 20pcs

$7.00
Add to cart

DROTAVERINE RENEVAL™ tablets 40mg, 28pcs

$9.00
Add to cart

DROTAVERINE solution for injection 20mg/ml (2ml), 10pcs

$11.00
Add to cart

GALIDOR™ solution for IV and IM injection 25mg/ml (2ml), 10pcs

$47.00
Add to cart

BRAL™ tablets 500mg+5mg+0.1mg, 100pcs

$36.00
Add to cart

BRAL™ tablets 500mg+5mg+0.1mg, 20pcs

$9.00
Add to cart
Select your currency